Investors in three Covid-19 vaccine makers on Thursday rejected shareholder proposals aimed at broadening global access to the shots.
Pfizer Moderna and Johnson & Johnson had opposed the proposals, saying they already had taken steps to expand access to their vaccines in poorer countries.
To Read the Full Story
This post first appeared on wsj.com
